CD44 and neoplasm: GCSCs have also been identified using specific markers, such as CD44 (Takaishi et al., 2009); the stemness properties of GCSCs are studied using two standard approaches: the in vitro sphere-forming assay and in vivo serial tumor passaging (Brungs et al., 2016).